title: An in-frame insertion in exon 3 and a nonsense mutation in exon 2 of the insulin receptor gene associated with severe insulin resistance in a patient with Rabson-Mendenhall syndrome.
abstract: We have studied the structure and function of the insulin receptor in a patient (PK) with severe insulin resistance and Rabson-Mendenhall syndrome. Insulin binding to cultured fibroblasts from PK was almost not detectable and insulin-induced insulin receptor autophosphorylation and glucose uptake was abolished. The structure of the receptor gene was analysed by sequencing amplified products of the 22 exons with the flanking intron regions directly as well as after subcloning in pUCBM20 plasmids. Two mutant alleles of the insulin receptor gene were detected. One allele contains in-frame 12 additional base pairs in exon 3 coding for the amino acids Leu-His-Leu-Val located between Asp-261 and Leu-262 in the receptor's extracellular domain, being the first report of an insertion mutation of the insulin receptor gene. In the other allele Arg-86 in exon 2 is changed into a stop codon. Therefore, PK is compound heterozygous at the insulin receptor locus. Direct cDNA sequencing indicates that both mutant alleles are expressed in the patient's fibroblasts. Studies of the parents' fibroblasts revealed that PK inherited the insertion mutation from the father and the nonsense mutation from the mother. Insulin binding to fibroblasts of the mother was reduced (63% of control cells) and hormone binding to the father's cells shows a larger reduction (37% of control cells), but less severe than the patient's cells (11% of control). This investigation provides further evidence that the Rabson-Mendenhall syndrome is causally related to mutations in the insulin receptor gene.
authors.affiliation: Klinik II und Poliklinik für Innere Medizin, Universität zu Köln, Cologne, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Müller-Wieland
authors.forename: E R
authors.initials: ER
authors.lastname: van der Vorm
authors.forename: R
authors.initials: R
authors.lastname: Streicher
authors.forename: W
authors.initials: W
authors.lastname: Krone
authors.forename: E
authors.initials: E
authors.lastname: Seemanova
authors.forename: M
authors.initials: M
authors.lastname: Dreyer
authors.forename: H W
authors.initials: HW
authors.lastname: Rüdiger
authors.forename: S R
authors.initials: SR
authors.lastname: Rosipal
authors.forename: J A
authors.initials: JA
authors.lastname: Maassen
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D002478:Cells, Cultured; D002648:Child; D017931:DNA Primers; D004251:DNA Transposable Elements; D005091:Exons; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance / Q000235:genetics*; D007700:Kinetics; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation; D010766:Phosphorylation; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D017526:Receptor, IGF Type 1 / Q000378:metabolism; D011972:Receptor, Insulin / Q000235:genetics* / Q000378:metabolism; D012867:Skin / Q000378:metabolism; D013577:Syndrome
chemical_list: D017931:DNA Primers; D004251:DNA Transposable Elements; D007328:Insulin; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin